TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells
Glenn M. Marshall(Children's Cancer Institute Australia), Belamy B. Cheung(Children's Cancer Institute Australia)
Cited by 70
Related Papers
TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members
|PLoS ONE|2012|115
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
|Nature Communications|2021|87
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients
|Cancer Letters|2016|64